NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, has announced it will report financial results for the third quarter of 2024 after market close on Tuesday, November 12, 2024. The company's management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors can access a live and archived webcast of the event at the provided link. Those interested in participating via telephone can dial +1-877-407-3982 and reference Conference ID 13749123. The webcast will be archived on the company's investor relations website for at least 90 days after the event.
NeuroPace, Inc. (Nasdaq: NPCE), un'azienda di dispositivi medici focalizzata nel trasformare la vita delle persone affette da epilessia, ha annunciato che riporterà i risultati finanziari per il terzo trimestre del 2024 dopo la chiusura del mercato martedì 12 novembre 2024. Il management dell'azienda ospiterà una call di conferenza corrispondente che inizierà alle 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Gli investitori possono accedere a una diretta e a una registrazione dell'evento al link fornito. Coloro che sono interessati a partecipare via telefono possono comporre il numero +1-877-407-3982 e fare riferimento all'ID Conferenza 13749123. La registrazione della web conference sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda per almeno 90 giorni dopo l'evento.
NeuroPace, Inc. (Nasdaq: NPCE), una empresa de dispositivos médicos centrada en transformar la vida de las personas con epilepsia, ha anunciado que reportará los resultados financieros del tercer trimestre de 2024 después del cierre del mercado el martes 12 de noviembre de 2024. La dirección de la empresa llevará a cabo una conferencia telefónica correspondiente que comenzará a las 1:30 p.m. Hora del Pacífico / 4:30 p.m. Hora del Este.
Los inversores pueden acceder a una transmisión en vivo y grabada del evento en el enlace proporcionado. Aquellos interesados en participar por teléfono pueden marcar +1-877-407-3982 y hacer referencia al ID de la Conferencia 13749123. La transmisión se archivará en el sitio web de relaciones con inversores de la empresa durante al menos 90 días después del evento.
NeuroPace, Inc. (Nasdaq: NPCE)는 간질 환자들의 삶을 변화시키는 데 집중하는 의료 기기 회사로, 2024년 3분기 재무 결과를 2024년 11월 12일 화요일 시장 종료 후 발표할 것이라고 발표했습니다. 회사 경영진은 태평양 표준시 기준 오후 1:30 / 동부 표준시 기준 오후 4:30에 해당하는 콘퍼런스콜을 진행할 예정입니다.
투자자는 제공된 링크를 통해 이 이벤트의 실시간 및 아카이브 된 웹캐스트에 접근할 수 있습니다. 전화로 참여하고자 하는 분은 +1-877-407-3982로 전화하신 후 콘퍼런스 ID 13749123을 참조하시면 됩니다. 이 웹캐스트는 이벤트 후 최소 90일 동안 회사의 투자자 관계 웹사이트에 아카이브될 것입니다.
NeuroPace, Inc. (Nasdaq: NPCE), une entreprise de dispositifs médicaux axée sur la transformation de la vie des personnes atteintes d'épilepsie, a annoncé qu'elle présentera ses résultats financiers du troisième trimestre 2024 après la fermeture du marché le mardi 12 novembre 2024. La direction de l'entreprise animera une conférence téléphonique correspondante à 13h30 heure du Pacifique / 16h30 heure de l'Est.
Les investisseurs peuvent accéder à un webinaire en direct et archivé de l'événement via le lien fourni. Ceux qui souhaitent participer par téléphone peuvent composer le +1-877-407-3982 et faire référence à l'ID de la conférence 13749123. Le webinaire sera archivé sur le site des relations avec les investisseurs de l'entreprise pendant au moins 90 jours après l'événement.
NeuroPace, Inc. (Nasdaq: NPCE), ein Unternehmen für medizinische Geräte, das sich auf die Transformation des Lebens von Menschen mit Epilepsie konzentriert, hat angekündigt, dass es die Finanzergebnisse für das dritte Quartal 2024 nach Börsenschluss am Dienstag, den 12. November 2024 bekannt geben wird. Das Management des Unternehmens wird eine entsprechende Telefonkonferenz ab 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time veranstalten.
Investoren können über den bereitgestellten Link auf eine Live- und archivierte Webcast des Ereignisses zugreifen. Interessierte, die telefonisch teilnehmen möchten, können die Nummer +1-877-407-3982 wählen und die Konferenz-ID 13749123 angeben. Der Webcast wird für mindestens 90 Tage nach dem Event auf der Investor-Relations-Website des Unternehmens archiviert.
- None.
- None.
MOUNTAIN VIEW, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2024 after market close on Tuesday, November 12, 2024. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://viavid.webcasts.com/starthere.jsp?ei=1690707&tp_key=080b652fbc. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13749123. The webcast will be archived on the company’s investor relations website at https://investors.neuropace.com/news-and-events/events and will be available for replay for at least 90 days after the event.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When will NeuroPace (NPCE) report its Q3 2024 financial results?
How can investors access NeuroPace's (NPCE) Q3 2024 earnings call?
What time is NeuroPace's (NPCE) Q3 2024 earnings conference call?